Craft

ONWARD

Stock Price

€4.9

2024-10-29

Market Capitalization

€169.7 M

2024-10-29

Revenue

€5.4 M

FY, 2025

ONWARD Summary

Company Summary

Overview
ONWARD Medical (formerly known as GTX Medical and G-Therapeutics) is a medical technology company. It is engaged in the development and commercializing of therapies to enable functional recovery for people with spinal cord injuries. The company offers upper and lower limb movement, blood pressure management, Parkinson's disease, and ARC therapies.
Type
Public
Status
Active
Founded
2014
HQ
Eindhoven, NL | view all locations
Website
https://www.onwd.com/
Cybersecurity rating
Sectors

Key People

  • Dave Marver

    Dave Marver, Chief Executive Officer

  • Grégoire Courtine

    Grégoire Courtine, Chief Scientific Officer, Co-Founder

  • Julien Camisani

    Julien Camisani, Vice President, Engineering

  • Lorenzo Fanti

    Lorenzo Fanti, Vice President, Legal

LocationsView all

2 locations detected

  • Eindhoven, NB HQ

    Netherlands

    Schimmelt 2

  • Eindhoven, NB

    Netherlands

    High Tech Campus, Building 32

ONWARD Financials

Summary Financials

Revenue (FY, 2025)
€5.4M
Gross profit (FY, 2025)
€4.4M
Net income (FY, 2025)
(€41.8M)
Cash (FY, 2025)
€68.1M
EBIT (FY, 2025)
(€40.9M)
Enterprise value
$114.6M

Footer menu